Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

1391 ARTÍCULOS , VIENDO DEL 1066 AL 1080

MS4A Cluster in Alzheimer's Disease

Ma J, Yu JT, Tan L.

Mol Neurobiol. 2015;51(3):1240-8. doi: 10.1007/s12035-014-8800-z. Epub 2014 Jul 1.

Association of UBQ-8i polymorphism with Alzheimer's disease in Caucasians: a meta-analysis

Yue Z, Wang S, Yan W, Zhu F.

Int J Neurosci. 2015 Jun;125(6):395-401. doi: 10.3109/00207454.2014.943369. Epub 2014 Aug 8.

Alzheimer disease and cancer risk: a meta-analysis

Shi HB, Tang B, Liu YW, Wang XF, Chen GJ.

J Cancer Res Clin Oncol. 2015 Mar;141(3):485-94. doi: 10.1007/s00432-014-1773-5. Epub 2014 Jul 12.

Role of traditional nonsteroidal anti-inflammatory drugs in Alzheimer's disease: a meta-analysis of randomized clinical trials

Gupta PP, Pandey RD, Jha D, Shrivastav V, Kumar S.

Am J Alzheimers Dis Other Demen. 2015 Mar;30(2):178-82. doi: 10.1177/1533317514542644. Epub 2014 Jul 13.

Infection, inflammation and Alzheimer's disease

Schott JM.

Eur J Neurol. 2015 Dec;22(12):1503-4. doi: 10.1111/ene.12522. Epub 2014 Jul 17.

Axonal transport defects in Alzheimer's disease

Wang ZX, Tan L, Yu JT.

Mol Neurobiol. 2015;51(3):1309-21. doi: 10.1007/s12035-014-8810-x. Epub 2014 Jul 23.

TYROBP in Alzheimer's disease

Ma J, Jiang T, Tan L, Yu JT.

Mol Neurobiol. 2015 Apr;51(2):820-6. doi: 10.1007/s12035-014-8811-9. Epub 2014 Jul 23.

Analyzing 54,936 Samples Supports the Association Between CD2AP rs9349407 Polymorphism and Alzheimer's Disease Susceptibility

Chen H, Wu G, Jiang Y, Feng R, Liao M, Zhang L, Ma G, Chen Z, Zhao B, Li K, Yu C, Liu G.

Mol Neurobiol. 2015 Aug;52(1):1-7. doi: 10.1007/s12035-014-8834-2. Epub 2014 Aug 5.

Induction of salivary nerve growth factor by Yogic breathing: a randomized controlled trial

Balasubramanian S, Mintzer JE, Wahlquist AE.

Int Psychogeriatr. 2015 Jan;27(1):168-70. doi: 10.1017/S1041610214001616. Epub 2014 Aug 7.

Association of insulin degrading enzyme gene polymorphisms with Alzheimer's disease: a meta-analysis

Cheng H, Wang L, Shi T, Shang Y, Jiang L.

Int J Neurosci. 2015 May;125(5):328-35. doi: 10.3109/00207454.2014.941440. Epub 2014 Sep 16.

7T T₂*-weighted magnetic resonance imaging reveals cortical phase differences between early- and late-onset Alzheimer's disease

van Rooden S, Doan NT, Versluis MJ, Goos JD, Webb AG, Oleksik AM, van der Flier WM, Scheltens P, Barkhof F, Weverling-Rynsburger AW, Blauw GJ, Reiber JH, van Buchem MA, Milles J, van der Grond J.

Neurobiol Aging. 2015 Jan;36(1):20-6. doi: 10.1016/j.neurobiolaging.2014.07.006. Epub 2014 Jul 15.

Effect of unawareness on rehabilitation outcome in a randomised controlled trial of multicomponent intervention for patients with mild Alzheimer's disease

Fernández-Calvo B, Contador I, Ramos F, Olazarán J, Mograbi DC, Morris RG.

Neuropsychol Rehabil. 2015;25(3):448-77. doi: 10.1080/09602011.2014.948461. Epub 2014 Aug 14.

Microglial Aβ receptors in Alzheimer's disease

Yu Y, Ye RD.

Cell Mol Neurobiol. 2015 Jan;35(1):71-83. doi: 10.1007/s10571-014-0101-6. Epub 2014 Aug 23.

The δ latent dementia phenotype in the uniform data set: Cross-validation and extension

Gavett BE, Vudy V, Jeffrey M, John SE, Gurnani AS, Adams JW.

Neuropsychology. 2015 May;29(3):344-52. doi: 10.1037/neu0000128. Epub 2014 Aug 25.

Clearing the way for tau immunotherapy in Alzheimer's disease

Herrmann A, Spires-Jones T.

J Neurochem. 2015 Jan;132(1):1-4. doi: 10.1111/jnc.12845. Epub 2014 Aug 23.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias